Browse > Article
http://dx.doi.org/10.4062/biomolther.2009.17.1.25

Tamoxifen Suppresses Clusterin Level through Akt Inactivation and Proteasome Degradation in Human Prostate Cancer Cells  

Shim, Jae-Ho (College of Pharmacy, Chung-Ang University)
Choi, Chang-Su (College of Pharmacy, Chung-Ang University)
Lee, Eun-Chang (College of Pharmacy, Chung-Ang University)
Kim, Mie-Young (College of Pharmacy, Chung-Ang University)
Chun, Young-Jin (College of Pharmacy, Chung-Ang University)
Publication Information
Biomolecules & Therapeutics / v.17, no.1, 2009 , pp. 25-31 More about this Journal
Abstract
Clusterin is a heterodimeric sulfated glycoprotein and plays a role in many different types of cancer as a cell survival factor and helps cancerous cells to evade stress-induced apoptosis. To investigate whether the regulation of clusterin expression is involved in the mechanism of anticancer agent, we studied the effect of tamoxifen on clusterin expression in human prostate cancer PC-3 cells. Treatment of PC-3 cells with tamoxifen reduced cellular proliferation. Western blot analyses showed that treatment with tamoxifen suppressed clusterin expression in a concentration-dependent manner. Transfection with clusterin siRNA plasmid showed that clusterin is required for PC-3 cell survival. We found that tamoxifen resulted in a rapid decrease in the phosphorylation of Akt on Ser473 leading to prevent kinase activity. Expression of myristoylated Akt prevented tamoxifen-mediated clusterin downregulation. Interestingly, MG132, a wellknown proteasome inhibitor also recovered clusterin expression suppressed by tamoxifen. These data indicate that clusterin expression may be regulated by activation of Akt and ubiquitin-proteasome pathway plays an important role in tamoxifen-mediated clusterin suppression.
Keywords
Tamoxifen; Clusterin; Akt; Proteasome;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Tsubuki, S., Kawasaki, H., Saito, Y., Miyashita, N., Inomata, M. and Kawashima, S. (1993). Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem. Biophys. Res. Commun. 196, 1195-1201   DOI   ScienceOn
2 Wilson, M. R. and Easterbrook-Smith, S. B. (2000). Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25, 95-98   DOI   ScienceOn
3 Yoo, Y. A., Kim, Y. H., Kim, J. S. and Seo, J. H. (2008). The functional implications of Akt activity and TGF-${\beta}$ signaling in tamoxifen-resistant breast cancer. Biochim. Biophys. Acta. 1783, 438-447   DOI   ScienceOn
4 Zellweger, T., Chi, K., Miyake, H., Adomat, H., Kiyama, S., Skov, K. and Gleave, M. E. (2002). Enhanced radiosensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin. Cancer Res. 8, 3276-3284
5 Jones, S. E. and Jomary, C. (2002). Clusterin. Int. J. Biochem. Cell. Biol. 34, 427-431   DOI   ScienceOn
6 Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H. G., Tsang, B. K. and Cheng, J. Q. (2004). Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J. Biol. Chem. 279, 5405-5412   DOI   ScienceOn
7 Sowery, R. D., Hadaschik, B. A., So, A. I., Zoubeidi, A., Fazli, L., Hurtado-Coll, A. and Gleave, M. E. (2008). Clusterin knockdown using the antisense oligonucleotide OGX-11 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy. BJU Int. 102, 389-397   DOI   ScienceOn
8 Zhou, H., Li, X.-M., Meinkoth, J. and Pittman, R. N. (2000). Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell. Biol. 151, 483-494   DOI
9 Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868   DOI   ScienceOn
10 Miyake, H., Hara, I., Gleave, M. E. and Eto, H. (2004). Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61, 318-323   DOI   ScienceOn
11 Petropoulou, C., Trougakos, I. P., Kolettas, E., Toussaint, O. and Gonos, E. S. (2001). Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 509, 287-297   DOI   ScienceOn
12 Collard, M. W. and Griswold, M. D. (1987). Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 26, 3297-3303   DOI   ScienceOn
13 Feng, J., Tamaskovic, R., Yang, Z., Brazil, D. P., Merlo, A., Hess, D. and Hemmings, B. A. (2004). Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J. Biol. Chem. 279, 35510-35517   DOI   ScienceOn
14 Jordan, V. C. (2007). Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat. Rev. Cancer 7, 46-53   DOI   ScienceOn
15 Trougakos, I. P., Lourda, M., Agiostratidou, G., Kletsas, D. and Gonos, E. S. (2005). Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic. Biol. Med. 38, 436-449   DOI   ScienceOn
16 Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R. and Wang, C. Y. (2005). Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7, 909-915   DOI   ScienceOn
17 Blaschuk, O., Burdzy, K. and Fritz, I. B. (1983). Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 258, 7714-7720
18 Hilt, W. and Wolf, D. H. (1996). Proteasomes: destruction as a programme. Trends Biochem. Sci. 21, 96-102   DOI   ScienceOn
19 Ammar H. and Closset, J. L. (2008). Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283, 12851-12861   DOI   ScienceOn
20 Bettuzzi, S., Scorcioni, F., Astancolle, S., Davalli, P., Scaltriti, M. and Corti, A. (2002). Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21, 4328-4334   DOI   ScienceOn
21 Caccamo, A. E., Scaltriti, M., Caporali, A., D'Arca, D., Scorcioni, F., Candiano, G., Mangiola, M. and Bettuzzi, S. (2003). Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann. N Y Acad. Sci. 1010, 514-519   DOI   ScienceOn
22 Cervellera, M., Raschella, G., Santilli, G., Tanno, B., Ventura, A., Mancini, C., Sevignani, C., Calabretta, B. and Sala, A. (2000). Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J. Biol. Chem. 275, 21055-21060   DOI   ScienceOn
23 Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J. and Dove, W. F. (2003). Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl. Acad. Sci. USA. 100, 9530-9535   DOI   ScienceOn
24 Clark, A. S., West, K., Streicher, S. and Dennis, P. A. (2002). Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707-717
25 Dumont, P., Chainiaux, F., Eliaers, F., Petropoulou, C., Remacle, J., Koch-Brandt, C., Gonos, E. S. and Toussaint, O. (2002). Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 7, 23-35   DOI   ScienceOn
26 El Etreby, M. F., Liang, Y. and Lewis, R. W. (2000). Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate 43, 31-42   DOI   ScienceOn
27 Gleave, M. E., Miyake, H., Zellweger, T., Chi, K., July, L., Nelson, C. and Rennie, P. (2001). Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Urology 58, 39-49   DOI   ScienceOn
28 Jordan, N. J., Gee, J. M., Barrow, D., Wakeling, A. E. and Nicholson, R. I. (2004). Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat. 87,167-180   DOI   ScienceOn
29 Jordan, V. C. (2006). Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br. J. Pharmacol. 147, S269-S276   DOI   ScienceOn
30 Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N. and Hay, N. (1997). The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713   DOI
31 Kuo, C. C., Liu, J. F., Shiah, H. S., Ma, L. C. and Chang, J. Y. (2007) Tamoxifen accelerates proteasomal degradation of $O^6$-methylguanine DNA methyltransferase in human cancer cells. Int. J. Cancer 121, 2293-2300   DOI   ScienceOn
32 So, A., Sinnemann, S., Huntsman, D., Fazli, L. and Gleave, M. (2005). Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol. Cancer Ther. 4, 1837-1849   DOI   ScienceOn
33 Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. and Boothman, D. A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590-11600   DOI   ScienceOn
34 Miyake, H., Nelson, C., Rennie, P. S. and Gleave, M. E. (2000). Testosterone expressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res. 60, 170-176
35 Ranney, M. K., Ahmed, I. S. A., Potts, K. R. and Craven, R. J. (2007). Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochim. Biophys. Acta. 1772, 1103-1111   DOI   ScienceOn
36 Tanno, B., Negroni, A., Vitali, R., Pirozzoli, M. C., Cesi, V., Mancini, C., Calabretta, B. and Raschellà, G. (2002). Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. J. Biol. Chem. 277, 23172-23180   DOI   ScienceOn
37 Trougakos, I. P., So, A., Jansen, B., Gleave, M. E. and Gonos, E. S. (2004). Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64, 1834-1842   DOI   ScienceOn